
Role of MTA1 in Cancer Progression and Metastasis - PMC
The MTA1 protein contributes to the process of cancer progression and metastasis through multiple genes and protein targets and interacting proteins with roles in transformation, anchorage-independent growth, invasion, survival, DNA-repair, angiogenesis, hormone-independence, metastasis and therapeutic resistance.
5'-Methylthioadenosine and Cancer: old molecules, new understanding
2019年1月29日 · Many studies indicate that MTA suppresses tumors by inhibiting tumor cell proliferation, invasion, and the induction of apoptosis while controlling the inflammatory micro-environments of tumor tissue. In this review, we assessed the effects of MTA and of related materials on the growth and functions of normal and malignant cells.
Enzyme-mediated depletion of methylthioadenosine restores T …
2023年9月28日 · Using clinical data on human melanoma and urothelial carcinoma and murine models, Gjuka et al. show that MTAP deletion and accumulation of MTA lead to an immune cold microenvironment through effects on both PRMT5 and adenosine receptors. Exogenous MTAP administration can reverse this effect, leading to immunotherapy responsiveness.
Structure, Expression and Functions of MTA Genes - PMC
In general, MTA1 and MTA2 are the most upregulated genes in human cancer and correlate well with aggressive phenotypes, therapeutic resistance, poor prognosis and ultimately, unfavorable survival of cancer patients. Here we will discuss the structure, expression and functions of the MTA family of genes in the context of cancer cells.
MTAP loss: a possible therapeutic approach for glioblastoma
2022年12月26日 · In this article, we review the loss of the 5′-methylthioadenosine phosphorylase (MTAP) gene as a potential therapeutic approach for treating glioblastoma. MTAP encodes a metabolic enzyme required for the metabolism of polyamines and purines leading to …
Targeting tumors that lack methylthioadenosine phosphorylase (MTAP ...
Many solid tumors and hematologic malignancies lack expression of the enzyme methylthioadenosine phosphorylase (MTAP), due either to deletion of the MTAP gene or to methylation of the MTAP promoter.
MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits …
2023年11月1日 · MRTX1719 selectively inhibited PRMT5 in the presence of MTA, which is elevated in MTAP del cancers, and inhibited PRMT5-dependent activity and cell viability with >70-fold selecti-vity in HCT116 MTAP del compared with HCT116 MTAP wild-type (WT) cells.
5'-Methylthioadenosine and Cancer: old molecules, new
2019年1月29日 · Many studies indicate that MTA suppresses tumors by inhibiting tumor cell proliferation, invasion, and the induction of apoptosis while controlling the inflammatory micro-environments of tumor tissue. In this review, we assessed the effects of MTA and of related materials on the growth and functions of normal and malignant cells.
Membrane-bound TNF mediates microtubule-targeting ... - Nature
2019年10月23日 · MemTNF-signaling-mediated apoptosis serves as the mechanism of action (MOA) for MTA/S-induced complete regression of human breast cancer. a Schematic experimental...
The Tumor Metabolite 5'-Deoxy-5'Methylthioadenosine (MTA
2024年12月20日 · Methylthioadenosine phosphorylase (MTAP), which catalyzes the degradation of 5'-deoxy-5'methylthioadenosine (MTA), is downregulated in many cancer entities. Consequently, MTA accumulates in the microenvironment of MTAP-deficient tumors, where it is known to inhibit tumor-infiltrating T cells and NK cells.